公开(公告)号：US20240185978A1

公开(公告)日：2024-06-06

申请号：US18538387

申请日：2023-12-13

Applicant: AbbVie Biotechnology Ltd.

Inventor： Peter Carl Stueckemann ,  Pankaj Dubey ,  Richard Lanier ,  Prakash Venkataramanan ,  Vaibhav Jindal ,  Shannon Marie Sword

IPC: G16H20/10 ,  G06Q30/06 ,  G06Q40/08 ,  G06Q50/22

CPC classification number: G16H20/10 ,  G06Q30/06 ,  G06Q40/08 ,  G06Q50/22

Abstract: A system for facilitating a medical order/prescription of a prescription product is provided. The system includes a memory device having stored therein a plurality of predefined forms, a receiver configured to receive (i) prescription product information from a healthcare provider (HCP) computing device, (ii) patient intake information, and (iii) a benefits summary in response to a benefits verification request, and a processor configured to generate the benefits verification request for the patient based on the patient intake information, select one of the predefined forms, populate the selected predefined form, generate a patient history based on at least one of the benefits summary and the populated form, and cause the patient history to be displayed on the HCP computing device, the displayed patient history including at least one of a date associated with receipt of the benefits summary by the HCP computing device and an expiration date of the populated form.

公开(公告)号：US20240177816A1

公开(公告)日：2024-05-30

申请号：US18433807

申请日：2024-02-06

Applicant: OrangeDot, Inc.

Inventor： Sai Moturu ,  Anmol Madan ,  Greg Elliott

IPC: G16H10/60 ,  G16H10/20 ,  G16H20/10 ,  G16H40/20 ,  G16H40/63 ,  G16H40/67 ,  G16H80/00

CPC classification number: G16H10/60 ,  G16H20/10 ,  G16H40/20 ,  G16H40/63 ,  G16H40/67 ,  G16H80/00 ,  G16H10/20

Abstract: Embodiments of a method and system for facilitating improvement of a user condition through tailored communication with a user can include receiving a log of use dataset associated with a digital communication behavior at a mobile device, the log of use dataset further associated with a time period; receiving a mobility supplementary dataset corresponding to a mobility-related sensor of the mobile device, the mobility supplementary dataset associated with the time period; determining a tailored communication plan for the user based on at least one of the log of use dataset and the mobility supplementary dataset; transmitting, based on the tailored communication plan, a communication to the user at the mobile device; and promoting a therapeutic intervention to the user in association with transmitting the communication.

公开(公告)号：US20240175088A1

公开(公告)日：2024-05-30

申请号：US18435880

申请日：2024-02-07

Applicant: The Board of Trustees of the Leland Stanford Junior University

Inventor： David M. Kurtz ,  Maximilian Diehn ,  Arash Ash Alizadeh

IPC: C12Q1/6886 ,  C12N15/10 ,  C12Q1/6869 ,  C12Q1/6874 ,  G16B20/00 ,  G16B20/10 ,  G16B20/20 ,  G16B30/00 ,  G16B30/10 ,  G16B35/20 ,  G16B40/00 ,  G16H10/40 ,  G16H20/10 ,  G16H50/20 ,  G16H50/30 ,  G16H50/70 ,  G16H70/60 ,  G16H10/60

CPC classification number: C12Q1/6886 ,  C12N15/1089 ,  C12Q1/6869 ,  C12Q1/6874 ,  G16B20/00 ,  G16B20/10 ,  G16B20/20 ,  G16B30/00 ,  G16B30/10 ,  G16B35/20 ,  G16B40/00 ,  G16H10/40 ,  G16H20/10 ,  G16H50/20 ,  G16H50/30 ,  G16H50/70 ,  G16H70/60 ,  C12Q2600/112 ,  C12Q2600/156 ,  C12Q2600/158 ,  G01N2800/7028 ,  G16H10/60

Abstract: Processes and materials to detect cancer from a biopsy are described. In some cases, cell-free nucleic acids can be sequenced, and the sequencing result can be utilized to detect sequences derived from a neoplasm. Detection of somatic variants occurring in phase can indicate the presence of cancer in a diagnostic scan and a clinical intervention can be performed.

公开(公告)号：US11996189B2

公开(公告)日：2024-05-28

申请号：US17448310

申请日：2021-09-21

Applicant: Bluesight, Inc.

Inventor： Kevin William MacDonald ,  Timothy James Leo Kress-Spatz

IPC: G16H40/63 ,  G06K7/10 ,  G06Q10/087 ,  G06Q10/0875 ,  G06Q10/10 ,  G16H15/00 ,  G16H20/10 ,  G16H40/40 ,  G16H40/67 ,  G16Z99/00 ,  H04W4/80

CPC classification number: G16H40/63 ,  G06K7/10415 ,  G06Q10/087 ,  G06Q10/0875 ,  G06Q10/10 ,  G16H15/00 ,  G16H20/10 ,  G16H40/40 ,  G16H40/67 ,  G16Z99/00 ,  H04W4/80

Abstract: A system for managing pharmacy kits comprises a reading station configured to read tag information from a plurality of radio frequency identification (RFID) tags associated with a pharmacy kit, and an information processing system operatively connected to the reading station and configured to receive the tag information from the reading station and determine a status of the pharmacy kit based on the tag information, a plurality of stored templates defining contents to be included in each of a plurality of pharmacy kits, and a plurality of kit records indicating the current contents of a plurality of pharmacy kits.

公开(公告)号：US20240164708A1

公开(公告)日：2024-05-23

申请号：US18524346

申请日：2023-11-30

Applicant: Eyenovia, Inc.

Inventor： Bernard L. Ballou, JR. ,  Mark Packer ,  Russell John Mumper ,  Tsontcho Ianchulev

IPC: A61B5/00 ,  A61B3/14 ,  A61B5/11 ,  A61F9/00 ,  A61K8/06 ,  A61K9/00 ,  A61M11/00 ,  A61M11/04 ,  A61M15/00 ,  A61M15/02 ,  B05B17/00 ,  B05B17/06 ,  G16H10/60 ,  G16H15/00 ,  G16H20/10 ,  G16H20/17 ,  G16H30/20 ,  G16H40/63 ,  G16H40/67 ,  G16Z99/00

CPC classification number: A61B5/4839 ,  A61B3/14 ,  A61F9/0008 ,  G16H20/10 ,  A61B5/0059 ,  A61B5/0079 ,  A61B5/1103 ,  A61F9/00 ,  A61F9/0026 ,  A61K8/06 ,  A61K9/0048 ,  A61M11/00 ,  A61M11/005 ,  A61M11/042 ,  A61M15/008 ,  A61M15/0083 ,  A61M15/025 ,  A61M2205/0205 ,  A61M2205/0238 ,  A61M2205/3306 ,  A61M2205/3368 ,  A61M2205/3553 ,  A61M2205/3584 ,  A61M2205/3592 ,  A61M2205/36 ,  A61M2205/3673 ,  A61M2205/50 ,  A61M2205/581 ,  A61M2205/582 ,  A61M2205/583 ,  A61M2205/587 ,  A61M2205/8206 ,  A61M2209/086 ,  A61M2210/0612 ,  B05B17/0646 ,  B05B17/0661 ,  B05B17/0676 ,  G16H10/60 ,  G16H15/00 ,  G16H20/17 ,  G16H30/20 ,  G16H40/63 ,  G16H40/67 ,  G16Z99/00

Abstract: The present invention includes and provides a method of delivering a medicament to an eye of a subject in need thereof a solution, the method comprising: (a) providing droplets containing the medicament with a specified average size and average initial ejecting velocity, and (b) delivering the medicament to the eye, where the droplets deliver a percentage of the ejected mass of the droplets to the eye.

公开(公告)号：US11986446B2

公开(公告)日：2024-05-21

申请号：US17562787

申请日：2021-12-27

Applicant: Jazz Pharmaceuticals Ireland Limited

Inventor： Mark Eller

IPC: A61K31/19 ,  A61K31/20 ,  A61K31/33 ,  A61K31/505 ,  A61K31/55 ,  A61K31/616 ,  A61P11/00 ,  A61P25/20 ,  A61P43/00 ,  G16H20/10

CPC classification number: A61K31/19 ,  A61K31/20 ,  A61K31/33 ,  A61K31/505 ,  A61K31/55 ,  A61K31/616 ,  A61P11/00 ,  A61P25/20 ,  A61P43/00 ,  G16H20/10 ,  A61K31/19 ,  A61K2300/00 ,  A61K31/20 ,  A61K2300/00 ,  A61K31/616 ,  A61K2300/00 ,  A61K31/196 ,  A61K2300/00

Abstract: One embodiment of the present invention is to improve the safety and efficacy of the administration of GHB or a salt thereof to a patient. It has been discovered that the concomitant administration of an MCT inhibitor, such as diclofenac, valproate, or ibuprofen, will affect GHB administration. For example, it has been discovered that diclofenac lowers the effect of GHB in the body, thereby potentially causing an unsafe condition. Furthermore, it has been discovered that valproate increases the effect of GHB on the body, thereby potentially causing an unsafe condition.

公开(公告)号：US20240161906A1

公开(公告)日：2024-05-16

申请号：US18103406

申请日：2023-01-30

Applicant: PillWork Inc.

Inventor： Young Gae CHO ,  So Ra NAM

IPC: G16H20/90 ,  G16H10/20 ,  G16H20/10 ,  G16H20/30

CPC classification number: G16H20/90 ,  G16H10/20 ,  G16H20/10 ,  G16H20/30

Abstract: A method for an online prescription platform may include providing main information based on user information, processing health information based on the user information, analyzing nutritional supplement ranking information based on the user information, and providing recommendation information and column information by receiving an input signal from a user.

公开(公告)号：US20240161897A1

公开(公告)日：2024-05-16

申请号：US18419105

申请日：2024-01-22

Applicant: CareFusion 303, Inc.

Inventor： David D. SWENSON

IPC: G16H20/13 ,  G06Q50/22 ,  G07F17/00 ,  G16H20/10 ,  G16H40/20 ,  G16H50/20

CPC classification number: G16H20/13 ,  G06Q50/22 ,  G07F17/0092 ,  G16H20/10 ,  G16H40/20 ,  G16H50/20

Abstract: A system, including a memory storing instructions and a processor configured to execute the instructions is provided. The instructions executed by the processor cause the system to retrieve a diagnostic information for a patient, to retrieve a physician information for a physician in charge of the patient, and to determine an anticipated medication prescription for the patient based on the diagnostic information, the physician information, and a medication prescribing pattern stored in the memory. A method for using the system and a non-transitory, computer readable medium including the instructions are also provided.

公开(公告)号：US20240161895A1

公开(公告)日：2024-05-16

申请号：US18505735

申请日：2023-11-09

Applicant: Alerje, Inc.

Inventor： Javier Evelyn

IPC: G16H20/10 ,  G16H10/60

CPC classification number: G16H20/10 ,  G16H10/60

Abstract: A method for predicting an adverse symptom to immunotherapy. The method comprises receiving a medical history and one or more therapy features, related to a food allergy, of a patient; evaluating a probability of the patient experiencing, respectively, each of one or more symptoms during immunotherapy; communicating the probability for each of the one or more symptoms to the patient and/or a physician of the patient.

公开(公告)号：US20240153607A1

公开(公告)日：2024-05-09

申请号：US18310791

申请日：2023-05-02

Applicant: Arcascope Inc.

Inventor： Olivia Walch ,  Kevin Hannay

IPC: G16H20/10 ,  G16H10/60 ,  G16H40/60 ,  G16H50/50

CPC classification number: G16H20/10 ,  G16H10/60 ,  G16H40/60 ,  G16H50/50

Abstract: A method of treatment and/or a treatment plan for administering a substance to a patient or performing a procedure on the patient can be timed using a modified scheduling process, implemented typically as a computer process, wherein a nonlinear treatment mapping is based on circadian trajectories computed from patient-specific inputs and uncertainty ranges.